Bovine Respiratory Disease is one of the most common diseases affecting beef cattle globally. It is a complex respiratory disease caused by various pathogens such as viruses, bacteria, fungus, and parasites. Major viruses include ParaInfluenza 3 (PI3), Bovine Respiratory Syncytial Virus (BRSV), Infectious Bovine Rhinotracheitis (IBR), Adenovirus, and Bovine Viral Diarrhea Virus (BVDV). Furthermore, Mycoplasma bovis, Pasteurella multocida, Histophilus somni, and Mannheimia haemolytica are the major bacteria’s responsible for the bovine respiratory disease.
Key factors responsible for the disease is a stress. Stressors for the bovine include changes of feed, weaning, variation in ambient weather, temperature, and humidity. Based on the age of the animal, stage of the disease, and the causative organisms, there is a significant variation in clinical signs of the bovine respiratory disease. However, key respiratory signs include rapid, shallow breathing; coughing; salivation; and bloody nasal and eye discharge. Other general symptoms include fever, depression, and lack of appetite. Diagnosis of the bovine respiratory disease is made on the basis of clinical signs though additional examination often needed. The examination includes nasopharyngeal swabs, tracheal washings, and blood samples examination. The key to preventing respiratory disease is to vaccinate the cattle against bacteria and viruses that are responsible for a disease. Financial losses due to bovine respiratory disease include mortality, the labor cost of the treatment, and medication. Continuous increase in the bovine respiratory disease and high cost of the treatment is likely to boost the global market.
The global bovine respiratory disease treatment market can be segmented into anti-infectious agents, anti-parasiticides, bronchodilators, oral rehydration fluids, non-steroidal anti-inflammatories, and mucolytic based on the type of treatment. Anti-infectious can be further sub-segmented into antibiotics and sulfas. Presently, anti-infectious agent is expected to maintain its share during the forecast period due to an effectiveness of the antibiotics. Furthermore, combination treatment with antibiotics and anti-inflammatory drugs have been evaluated which has known to improve the success rate of the treatment. Newer antibiotics for the treatment of bovine respiratory disease are Micotil, Nuflor, and Baytril 100 in addition to the commonly administered antibiotics such as Adspec, Excenel, and Naxcel. Hence, development of newer generation antibiotics for cattle would lead to increasing demand of the antibiotics therapy.
Geographically, the bovine respiratory disease treatment market has been segmented into five regions: North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The regions are further analyzed in details for the major contributing countries such as the U.S., Canada, U.K., Germany, France, Italy, Spain, India, China, Japan, Mexico, Brazil, and South Africa. North America leads the market due to higher prevalence bovine respiratory disease incurring higher cost in the U.S. Additionally, well established animal healthcare market and increasing number of veterinary practitioners are the major drivers for the North America market. In the US beef industry, the disease continues to be the primary cause of mortality and morbidity in feedlots contributing to losses in performance, and health. Asia Pacific is a fastest growing region for the bovine respiratory disease treatment market owing to rising cattle adoption in China and India; and presence of major market players in the region. However, increasing adoption of vaccination for number of agents lead to decrease in the demand for treatment.
The major players operating in the global bovine respiratory disease treatment market are Zoetis, Inc., Merck & Co. Inc., Bayer Corporation, Eli Lilly & Co., and Others.
The report offers a comprehensive evaluation of the market. It does so via in-depth insights, understanding market evolution by tracking historical developments, and analyzing the present scenario and future projections based on optimistic and likely scenarios. Each research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology developments, types, applications, and the competitive landscape.
The study is a source of reliable data on:
- Key market segments and sub-segments
- Evolving market trends and dynamics
- Changing supply and demand scenarios
- Quantifying market opportunities through market sizing and market forecasting
- Tracking current trends/opportunities/challenges
- Competitive insights
- Opportunity mapping in terms of technological breakthroughs
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, Luxembourg)
- Eastern Europe (Poland, Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia and New Zealand)
- Middle East and Africa (GCC, Southern Africa, North Africa)
TMR estimates the market size of various sectors using a combination of available data on the number and revenue of companies within each sub-sector and tiers of companies. The basic components used to determine market size and forecast for a specific product area are not only limited to supply-side data, but are also related to demand, industry trends, and the economic outlook. All the above data points are utilized to generate a statistical model targeting the sector marketplace. More than 300 TMR analysts across the world integrate these elements into a framework to determine the subsector market size for a base year and then forecast growth within each market.
TMR regularly interviews technology and business professionals as an ongoing effort to track the latest developments within each sector. These continuous surveys are stratified by company size and industry segment and weighted to reflect the global market place. All data are collected on an ongoing effort through a structured questionnaire rolled over the web or conducted via telephones. This provides the TMR team opportunities to request for detailed question sets, complex skip patterns, and real-time calculations, which assists respondents in answering questions involving numbers and percentages. Respondents, who are interviewed as experts, are screened and qualified based on certain criteria in addition to their decision-making authority and the scope of activity within their organizations.
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.